UNII G2M7P15E5P

POLYETHYLENE GLYCOL 3350

Unique Ingredient Identifier G2M7P15E5P is listed as a ingredient substance
UniiG2M7P15E5P
Preferred Substance NamePOLYETHYLENE GLYCOL 3350
Rn25322-68-3
NcitC80131
Rxcui221147
Unii TypeINGREDIENT SUBSTANCE
RN25322-68-3
NCITC80131
RXCUI221147
MFPolymer substance not supported

Alternate Names

Dosage Forms

UNII G2M7P15E5P POLYETHYLENE GLYCOL 3350 is commonly included in medications in the following forms.

RouteDosage FormPotency
INTRA-ARTERIALSUSPENSION, INJECTION29.1 mg/1mL
INTRA-ARTICULARINJECTION3 %
INTRALESIONALINJECTABLE2.91 %
INTRALESIONALINJECTION3 %
INTRALESIONALINJECTION, SUSTAINED ACTION2.9 %
INTRALESIONALSUSPENSION, INJECTION29.1 mg/1mL
INTRALESIONALSUSPENSION, INJECTION2.91 %
INTRAMUSCULARINJECTABLE2.91 %W/V
INTRAMUSCULARINJECTION6 %W/V
INTRAMUSCULARINJECTION, SUSPENSION2.89 %
INTRAMUSCULARINJECTION, SUSTAINED ACTION2.9 %W/V
INTRAMUSCULARSUSPENSION, INJECTION29.1 mg/1mL
INTRAMUSCULARSUSPENSION, INJECTION2.91 %W/V
INTRASYNOVIALINJECTABLE2.91 %
INTRASYNOVIALINJECTION3 %
INTRASYNOVIALINJECTION, SUSTAINED ACTION2.9 %
INTRASYNOVIALSUSPENSION, INJECTION2.91 %
INTRA-SYNOVIALSUSPENSION, INJECTION29.1 mg/1mL
NASALSOLUTION40 %
NASALSPRAY, METERED1.5 %
ORALCAPSULE27.2 MG
ORALCAPSULE, EXTENDED RELEASE0.67 MG
ORALCAPSULE, HARD GELATIN288 MG
ORALCAPSULE, SOFT GELATIN76.92 MG
ORALSUSPENSION45 MG/1ML
ORALSUSPENSION0.12 MG/15ML
ORALSUSPENSION, EXTENDED RELEASE9.31 MG/5ML
ORALSUSPENSION, SUSTAINED ACTION NA
ORALTABLET25 MG
ORALTABLET (IMMED./COMP. RELEASE), FILM COATED9.7 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE15 MG
ORALTABLET, COATED0.5 MG
ORALTABLET, CONTROLLED RELEASE1.67 MG
ORALTABLET, DELAYED ACTION4.4 MG
ORALTABLET, DELAYED RELEASE2.43 mg
ORALTABLET, EXTENDED RELEASE20.2 MG
ORALTABLET, FILM COATED20 MG
ORALTABLET, FILM COATED2.42 MG
ORALTABLET, SUSTAINED ACTION6.75 MG
ORALTABLET, SUSTAINED ACTION, COATED8.5 MG
RECTALSUPPOSITORY1425.96 MG
SOFT TISSUEINJECTION3 %
SOFT TISSUEINJECTION, SUSTAINED ACTION2.9 %
SOFT TISSUESUSPENSION, INJECTION29.1 mg/1mL
SOFT TISSUESUSPENSION, INJECTION2.91 %
SUBCUTANEOUSSUSPENSION, INJECTION4.42 %
TOPICALCREAM4.6 %W/W
TOPICALCREAM4.5 %W/W
TOPICALOINTMENT40 %W/W
VAGINALSUPPOSITORY NA

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.